METHOD FOR SCREENING RESPONSIVENESS TO DRUGS EFFECTIVE IN TREATMENT OR PREVENTION OF VITILIGO AND METHOD FOR PROGNOSIS OF VITILIGO

摘要

The present invention relates to methods and kits for screening responsiveness to drugs effective in treatment or prevention of vitiligo, methods and kits for screening active ingredients effective in treatment or prevention of vitiligo, and methods and kits for prognosis of vitiligo using eukaryotic translation initiation factor 4A1 (eIF4A1) gene, ribosomal protein L13 (L13) gene and mediator of RNA polymerase to transcription (MRT) gene.